MENAFN

(MENAFN) Swiss health authorities have confirmed a case of hantavirus infection in a man who previously traveled aboard the MV Hondius cruise ship in the Atlantic Ocean, according to reports from the World Health Organization and local media on...

GlobeNewswire, Inc.

Successfully dosed all four planned healthy volunteer SAD cohorts of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Preliminary pharmacokinetic (PK) modeling from HEADLINE trial supports ABS-201's targeted...

GlobeNewswire, Inc.

$194.5 million in total first quarter revenues, comprised of $180.6 million of U.S. Attruby® net product revenue, with strong prescribing growth and patient persistence driving continued commercial momentum Continued broad uptake among all patient...

EIN Presswire

JFF to Steer Roundtable Discussion of Global Leaders and Policymakers Regarding the Use and Scale of Multiple Micronutrient Supplements for Maternal Health CLEVELAND, OH, UNITED STATES, May 7, 2026 /⁨EINPresswire.com⁩/ -- On May 22nd, 2026 the...

GlobeNewswire, Inc.

Strong start to the year with worldwide revenue of $377.3 million in the first quarter 2026 GAAP fully diluted earnings per share of $1.80, compared to $1.02 in the first quarter of 2025 Adjusted fully diluted earnings per share of $1.46, compared...

GlobeNewswire, Inc.

– Decisions on regulatory approval from EMA, UK, and Switzerland for obicetrapib and obicetrapib/ezetimibe fixed-dose combination expected in 2H26, and based on the outcomes, with potential launches by Menarini in 4Q26 in Germany and the UK – –...